bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.01.24.525308

TSD: Transformers for Seizure Detection

Abstract

Epilepsy is a common neurological disorder that sub-stantially deteriorates patients safety and quality of life. Electroencephalogram (EEG) has been the golden-standard technique for diagnosing this brain disorder and has played an essential role in epilepsy monitoring and disease management. It is extremely laborious and challenging, if not practical, for physicians and expert humans to annotate all recorded signals, particularly in long-term monitoring. The annotation process often involves identifying signal segments with suspected epileptic seizure features or other abnormalities and/or known healthy features. Therefore, automated epilepsy detection becomes a key clinical need because it can greatly improve clinical practices efficiency and free up human expert time to attend to other important tasks. Current automated seizure detection algorithms generally face two challenges: (1) models trained for specific patients, but such models are patient-specific, hence fail to generalize to other patients and real-world situations; (2) seizure detection models trained on large EEG datasets have low sensitivity and/or high false positive rates, often with an area under the receiver operating characteristic (AUROC) that is not high enough for potential clinical applicability. This paper proposes Transformers for Seizure Detection, which we refer to as TSD in this manuscript. A Transformer is a deep learning architecture based on an encoder-decoder structure and on attention mechanisms, which we apply to recorded brain signals. The AUROC of our proposed model has achieved 92.1%, tested with Temple Universitys publically available electroencephalogram (EEG) seizure corpus dataset (TUH). Additionally, we highlight the impact of input domains on the models performance. Specifically, TSD performs best in identifying epileptic seizures when the input domain is a time-frequency. Finally, our proposed model for seizure detection in inference-only mode with EEG recordings shows outstanding performance in classifying seizure types and superior model initialization.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ma, Y., Liu, C., Ma, M. S., Yang, Y., Truong, N. D., Kavehei, O.. 2023-01-24. TSD: Transformers for Seizure Detection. https://doi.org/10.1101/2023.01.24.525308

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Single-Component Photo-Crosslinked Lipoic Acid Functionalized Mucin Hydrogels: Dynamic Mucus Mimetics for Antiviral Protection

Native mucus protects epithelial surfaces through viscoelastic networks of disulfide-linked mucins. However, commercially available mucins often fail to reconstitute comparable mechanical and barrier properties, while synthetic and hybrid mucus mimetics require polymeric crosslinkers that may alter mucus-like composition. Inspired by the native architecture, we directly functionalized porcine gastric and bovine submaxillary mucins with -lipoic acid to develop a single-component, photo-crosslinkable hydrogels. Upon UV irradiation (365 nm), the modified mucins rapidly form disulfide-crosslinked networks without added photo-initiator/ polymeric crosslinkers, two orders of magnitude faster as compared with PEG-SH approaches. The resulting mucin-lipoic acid (MUC-LA) hydrogels exhibit mucus-relevant properties, including tunable viscoelasticity, redox responsiveness, self-healing, and size-dependent restrictions on nanoparticle transport. In transwell-based infection models, MUC-LA hydrogels (2-3%) mimicking the healthy airway mucus (G' {approx} 10-20 Pa) suppress epithelial infection by SARS-CoV-2 and influenza A virus. Crosslinked MUC-LA provides greater protection against SARS-CoV-2 than the non-crosslinked, whereas both formulations suppress influenza A infection, suggesting distinct contributions from network formation and mucin-associated interactions. These findings establish a dynamic, mucus-mimetic platform integrating rapid photo-gelation, controllable mechanics, selective transport, and antiviral barrier functionality. MUC-LA hydrogels offer opportunities to investigate mucosal transport and host-pathogen interactions, with potential applications in drug delivery, and as biomaterials.

bioengineering↗

A Fibrous Optofluidic Probe for Endovascular Sensing of Blood Oxygenation and Flow Velocity

Local hemodynamic information including blood oxygenation and flow velocity could guide vascular interventions, yet obtaining these parameters in deep, narrow vessels remains challenging. Here, we report a flexible, submillimeter-scale fibrous optofluidic probe for endovascular sensing of blood oxygenation and flow velocity. The probe integrates a polymer optical fiber for light transmission with a microfluidic tube for dye injection, enabling spectroscopic oximetry and fluorescence dilution-based velocimetry through a single device. Via vascular intervention, we demonstrate local hemodynamic sensing in rabbit arteries and angiography-guided deployment in canine carotid arteries. The probe captures local changes in blood oxygenation and flow velocity during vascular occlusion and reperfusion, revealing hemodynamic disturbances that are not reflected in peripheral monitors. These results illustrate the complementary information provided by local oximetry and velocimetry and establish a compact optofluidic platform for quantitative hemodynamic monitoring during vascular interventions.

bioengineering↗

Broad-spectrum in situ genetic reprogramming of native microbiomes

Complex microbial communities are found throughout terrestrial, aquatic, and animal-associated ecosystems. Genetic modification of discrete microbial taxa within native communities represents a powerful tool to study and augment microbiome functions. Herein, we develop Synthetic Phage Assisted Reprogrammable and Targetable Addition (SPARTA) as a one-step strategy for packaging, delivering, and integrating large synthetic DNA into a broad range of native microbiomes. SPARTA leverages a broad-spectrum synthetic phage particle for in situ genome engineering within complex soil, freshwater, and mammalian fecal microbiomes, reprogramming 59 native species across 16 families. By modulating SPARTA components, we further demonstrated tunability of SPARTA towards targeted microbiome population. Additionally, we built a novel companion tool to quantitatively identify engineered taxa, named 16S crRNA-guided inference of bacterial engineering sequencing or ScRibe-seq. The SPARTA-ScRibe-seq pipeline delivered and validated functional synthetic gene clusters in diverse native microbiomes while preserving the original microbial community structure. Together, this novel genome engineering framework constitutes an end-to-end programmable platform for rational and customizable reprogramming of native microbiomes.

bioengineering↗